Question

What was the type of study followed by Pfizer to develop the Vaccine for SARS-CoV-2?

What was the type of study followed by Moderna to develop the Vaccine for SARS-CoV-2?

Answer 1

1, SARS-CoV-2 is a severe acute respiratory syndrome coronavirus, this virus causes respiratory illness
in humans. type of study conducted as a research study is a clinical trial in people for making effective interventions. comparing an investigational vaccine against a placebo whether the vaccine will be effective or not that can prevent COVID-19 the researchers find out new treatment with new drugs to make it safe and effective in people.
Pfizer has a deep heritage for vaccine development, through study protocols, the methodology of a clinical trial designed to determine safe and effective intervention for COVID-19 prevention.
2, Moderna Inc's coronavirus vaccine ensures complete vaccination safety in older adults to reduce the risk of severe complications from COVID-19. Under the clinical trial study, Pfizer and Moderna have candidates. Moderna and the VRC(vaccination research center) testing higher doses in the large phase III trial as the final stage. moderna's phase I and II safety trial was conducted using a placebo-controlled, randomized, and double-blind study. vaccine from modern made exceed expectations in the pivotal trial. Moderna experimental vaccine more than 95% effective to prevent COVID-19 based on the clinical trial. clinical trial study design ensures the safety, immunogenicity, and reactogenicity of mRNA-1273 from Moderna.